HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laureline Berthelot Selected Research

IGA Glomerulonephritis (IGA Nephropathy)

3/2024The gut microbiota posttranslationally modifies IgA1 in autoimmune glomerulonephritis.
1/2023Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy.
11/2021Role of gut-kidney axis in renal diseases and IgA nephropathy.
1/2021Fecal Microbiota Transplantation Modulates Renal Phenotype in the Humanized Mouse Model of IgA Nephropathy.
1/2020Food antigens and Transglutaminase 2 in IgA nephropathy: Molecular links between gut and kidney.
1/2019Modulation of the microbiota by oral antibiotics treats immunoglobulin A nephropathy in humanized mice.
2/2016Role of IgA receptors in the pathogenesis of IgA nephropathy.
1/2016IgA1 Protease Treatment Reverses Mesangial Deposits and Hematuria in a Model of IgA Nephropathy.
12/2015Molecular Insights into the Pathogenesis of IgA Nephropathy.
10/2015Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Laureline Berthelot Research Topics

Disease

16IGA Glomerulonephritis (IGA Nephropathy)
03/2024 - 03/2011
9Inflammation (Inflammations)
01/2022 - 04/2012
7Multiple Sclerosis
01/2023 - 05/2004
7Proteinuria
01/2022 - 04/2012
5Glomerulonephritis
03/2024 - 01/2013
4Hematuria
01/2016 - 04/2012
3Autoimmune Diseases (Autoimmune Disease)
03/2024 - 01/2022
3Neuroinflammatory Diseases
01/2023 - 01/2018
3Relapsing-Remitting Multiple Sclerosis
01/2023 - 10/2008
3Chronic Kidney Failure (Chronic Renal Failure)
12/2015 - 01/2013
2Fibrosis (Cirrhosis)
02/2024 - 01/2016
2Kidney Diseases (Kidney Disease)
01/2023 - 11/2021
2Infections
01/2022 - 01/2019
2Vasculitis (Vasculitides)
01/2019 - 01/2018
2Nephritis
01/2018 - 01/2017
2Purpura
01/2018 - 01/2017
2Systemic Vasculitis
01/2018 - 01/2017
1Dysbiosis
03/2024
1Encephalomyelitis (Myeloencephalitis)
01/2023
1Astrocytoma (Pilocytic Astrocytoma)
01/2023
1Immune System Diseases (Immune Disorders)
01/2022
1Albuminuria
01/2021
1Monoclonal Gammopathy of Undetermined Significance
01/2020
1Nephrotic Syndrome (Syndrome, Nephrotic)
01/2018
1IgA Vasculitis (Purpura, Schoenlein Henoch)
01/2017
1Renal Insufficiency (Renal Failure)
01/2016
1Disease Progression
12/2015
1Atrophy
08/2015
1Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis)
12/2011
1Celiac Disease (Celiac Sprue)
03/2011
1Necrosis
05/2004

Drug/Important Bio-Agent (IBA)

18Immunoglobulin A (IgA)IBA
03/2024 - 03/2011
11Immunoglobulin G (IgG)IBA
03/2024 - 12/2011
5AntigensIBA
03/2024 - 01/2020
5Antigen-Antibody Complex (Immune Complex)IBA
03/2024 - 12/2011
5AntibodiesIBA
03/2024 - 08/2015
5AutoantibodiesIBA
11/2022 - 08/2015
4Immunoglobulins (Immunoglobulin)IBA
01/2022 - 12/2015
4IgA receptor (protein B)IBA
02/2016 - 04/2012
3Biomarkers (Surrogate Marker)IBA
01/2018 - 01/2017
2EpitopesIBA
03/2024 - 01/2022
2AutoantigensIBA
01/2023 - 06/2010
2Peptides (Polypeptides)IBA
01/2023 - 04/2012
2Galactose (Galactopyranose)FDA LinkGeneric
01/2022 - 12/2011
2Protein Glutamine gamma Glutamyltransferase 2IBA
01/2020 - 08/2015
2galactosyl-deficient IgA1IBA
01/2018 - 12/2015
2Proteins (Proteins, Gene)FDA Link
01/2018 - 06/2010
2Glutens (Glutelin)IBA
08/2015 - 04/2012
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
07/2008 - 05/2004
1DefensinsIBA
03/2024
1MucinsIBA
03/2024
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
02/2024
1EndopeptidasesIBA
02/2024
1Monoclonal AntibodiesIBA
01/2023
1Amino AcidsFDA Link
01/2023
1Inwardly Rectifying Potassium Channels (Inward Rectifier Potassium Channels)IBA
01/2023
1TunicamycinIBA
01/2023
1ocrelizumabIBA
01/2023
1Fc(alpha) receptorIBA
01/2022
1ChemokinesIBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2019
1Interleukin-10 (Interleukin 10)IBA
01/2018
1Interleukin-6 (Interleukin 6)IBA
01/2018
1Immunoglobulin M (IgM)IBA
01/2018
1TransferasesIBA
01/2018
1Interleukin-8 (Interleukin 8)IBA
01/2018
1Lipocalin-2IBA
01/2017
1CytokinesIBA
01/2017
1IgA-specific serine endopeptidaseIBA
01/2016
1CryoglobulinsIBA
01/2016
1Fc Receptors (Fc Receptor)IBA
12/2015
1glycosylated IgAIBA
10/2015
1Transferrin (beta 2 Transferrin)IBA
08/2015
1GliadinIBA
08/2015
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2012
1TransglutaminasesIBA
04/2012
1Glatiramer Acetate (Copaxone)FDA Link
04/2010
1Interleukin-7 Receptors (Interleukin 7 Receptor)IBA
10/2008
1Interleukin-2 (IL2)IBA
05/2004
1alpha-beta T-Cell Antigen Receptors (T-Cell Receptor alpha-Chain)IBA
05/2004
1Human Serum AlbuminFDA LinkGeneric
05/2004
1Complementarity Determining Regions (Complementarity Determining Region)IBA
05/2004
1Interferon-gamma (Interferon, gamma)IBA
05/2004
1EnzymesIBA
05/2004

Therapy/Procedure

2Kidney Transplantation
12/2015 - 10/2015
1Fecal Microbiota Transplantation
01/2021
1Heterologous Transplantation (Xenotransplantation)
01/2019
1Aftercare (After-Treatment)
01/2016
1Transplantation
12/2015
1Gluten-Free Diet
08/2015